Josep M. Llovet, MD, PhD is Professor of Medicine – Hepatic Oncology at University of Barcelona, Professor of Research-ICREA in the Liver Unit, IDIBAPS-Hospital Clínic of Barcelona and Director of the Liver Cancer Program and Full Professor of Medicine at the Icahn School of Medicine at Mount Sinai, New York.
Prof. Llovet has been President and Founder of the International Liver Cancer Association (ILCA) Chairman and panellist of ~10 guidelines of management and trial design in liver cancer, including chair of the EASL-CPG 2012, President of the AASLD-SIG of Hepatobiliary neoplasia and member of the Educational Committee of EASL. He has published more than 345 articles in peer-reviewed journals (number of citations: 136,049, total impact factor 8,365; h index 130) > 55 chapters of books, and has delivered more than 675 lectures. He has been Associate/Senior Editor of Journal of Hepatology and Clinical Cancer Research and is a Top-1% cited researcher in Clarivate Analytics (2014 to 2022).
He has devoted his career studying the pathogenesis and treatment of liver cancer and has received the AACR-Landon International Award (2009), the International Hans Popper award (2012), and has received competitive funding for ~100 projects including the European Commission and the US National Institute of Health